1. Home
  2. VIRC vs MXCT Comparison

VIRC vs MXCT Comparison

Compare VIRC & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VIRC

Virco Manufacturing Corporation

HOLD

Current Price

$6.11

Market Cap

99.1M

ML Signal

HOLD

Logo MaxCyte Inc.

MXCT

MaxCyte Inc.

HOLD

Current Price

$1.09

Market Cap

112.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIRC
MXCT
Founded
1950
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
99.1M
112.5M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
VIRC
MXCT
Price
$6.11
$1.09
Analyst Decision
Hold
Buy
Analyst Count
1
4
Target Price
$7.30
$5.50
AVG Volume (30 Days)
33.6K
989.6K
Earning Date
04-08-2026
05-12-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$199,652,000.00
$33,026,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$19.77
$18.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.16
$0.64
52 Week High
$9.07
$2.19

Technical Indicators

Market Signals
Indicator
VIRC
MXCT
Relative Strength Index (RSI) 51.86 42.54
Support Level $6.01 $0.77
Resistance Level $6.37 $1.16
Average True Range (ATR) 0.15 0.08
MACD 0.00 -0.02
Stochastic Oscillator 88.61 20.00

Price Performance

Historical Comparison
VIRC
MXCT

About VIRC Virco Manufacturing Corporation

Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.

About MXCT MaxCyte Inc.

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

Share on Social Networks: